Advertisement

Microbial Cell Factories

, 18:27 | Cite as

Production of l-alanyl-l-glutamine by immobilized Pichia pastoris GS115 expressing α-amino acid ester acyltransferase

  • Yi-Min Li
  • Jiao-Qi Gao
  • Xu-Ze Pei
  • Cong Du
  • Chao Fan
  • Wen-Jie YuanEmail author
  • Feng-Wu Bai
Open Access
RESEARCH
  • 109 Downloads

Abstract

Background

l-Alanyl-l-glutamine (Ala-Gln) represents the great application potential in clinic due to the unique physicochemical properties. A new approach was developed to synthesize Ala-Gln by recombinant Escherichia coli OPA, which could overcome the disadvantages of traditional chemical synthesis. Although satisfactory results had been obtained with recombinant E. coli OPA, endotoxin and the use of multiple antibiotics along with toxic inducer brought the potential biosafety hazard for the clinical application of Ala-Gln.

Results

In this study, the safer host Pichia pastoris was applied as an alternative to E. coli. A recombinant P. pastoris (named GPA) with the original gene of α-amino acid ester acyltransferase (SsAet) from Sphingobacterium siyangensis SY1, was constructed to produce Ala-Gln. To improve the expression efficiency of SsAet in P. pastoris, codon optimization was conducted to obtain the strain GPAp. Here, we report that Ala-Gln production by GPAp was approximately 2.5-fold more than that of GPA. The optimal induction conditions (cultivated for 3 days at 26 °C with a daily 1.5% of methanol supplement), the optimum reaction conditions (28 °C and pH 8.5), and the suitable substrate conditions (AlaOMe/Gln = 1.5/1) were also achieved for GPAp. Although most of the metal ions had no effects, the catalytic activity of GPAp showed a slight decrease in the presence of Fe3+ and an obvious increase when cysteine or PMSF were added. Under the optimum conditions, the Ala-Gln generation by GPAp realized the maximum molar yield of 63.5% and the catalytic activity of GPAp by agar embedding maintained extremely stable after 10 cycles.

Conclusions

Characterized by economy, efficiency and practicability, production of Ala-Gln by recycling immobilized GPAp (whole-cell biocatalyst) is represents a green and promising way in industrial.

Keywords

l-Alanyl-l-glutamine α-Amino acid ester acyltransferase Immobilization Codon optimization Recycle 

Abbreviations

Ala-Gln

l-alanyl-l-glutamine

Gly-Gln

glycyl-l-glutamine

Gln

l-glutamine

AlaOMe

l-alanine methyl ester hydrochloride

AlaOEt

l-alanine ethyl ester hydrochloride

AlaOiPr

l-alanine isopropyl ester hydrochloride

AlaOtBu

l-alanine tert-butyl ester hydrochloride

AlaOBzl

l-alanine benzyl ester hydrochloride

SsAet

α-amino acid ester acyltransferase from Sphingobacterium siyangensis SY1

SsAET

the original gene of SsAet

SsAETp

the codon optimized gene of SsAet

OPA

origami 2-pET29a(+)-SsAET

GPA

GS115-pPIC9-SsAET

GPAp

GS115-pPIC9-SsAETp

His+

histidine surplus

MutS

methanol utilization slow

Mut+

methanol utilization plus

AOX1

alcohol oxidase from AOX1 gene

YNB

yeast nitrogen base without amino acids

CAI

codon adaptation index

PITC

phenylisothiocyanate

PMSF

phenylmethanesulfonyl fluoride

EDTA

ethylene diamine tetraacetic acid

Background

As the major carrier of nitrogen in the body, l-glutamine (Gln), the most abundant free-form amino acids in the plasma [1], is a conditionally essential amino acid [2, 3]. That is, Gln needs outside supplement for body’s requirements under specific conditions such as strenuous exercise, injury, and infection [4]. However, the widespread clinical applications of free Gln are quite limited due to its unfavorable physicochemical properties [5, 6, 7].

An effective approach to overcome intrinsic limitations of Gln is glutamine-containing dipeptides by conjugation with other amino acids [8]. l-Alanyl-l-glutamine (Ala-Gln) and glycyl-l-glutamine (Gly-Gln) are supposed to be two main types of glutamine-containing dipeptides in clinical practice [9]. Ala-Gln has been clinically selected as the most suitable alternative of Gln because of its high thermostability under heat sterilization, highly solubility (568 g/L), and higher decomposition rate [10, 11]. Beyond that, Ala-Gln will be rapidly removed from plasma after parenteral administration without accumulation in tissues and undetectable in urine [12]. These properties indicate that Ala-Gln as an appropriate parenteral nutrition in clinic will become an essential for patients after operation and postoperative recovery [13, 14, 15], just like glucose solution or normal saline.

Generally, chemical methods have been utilized for industrial production of Ala-Gln. However, these chemical synthesis pathways have obvious disadvantages [16, 17]. These drawbacks may increase production costs and violate requirements of green chemistry in the 21st century. Compared with traditional chemical synthesis, microbial enzymatic synthesis has the broadest prospect due to the individual advantages such as simple operation, inexpensive raw materials, high conversion efficiency, environmentally friendly process, and recyclability in further industrial-scale applications [18]. Recently, a novel enzyme named α-amino acid ester acyltransferase (SsAet) was found in Sphingobacterium siyangensis AJ2458 by Abe et al. [19], which can generate Ala-Gln directly using l-alanine methyl ester hydrochloride (AlaOMe) and Gln. Heterologous expression system of SsAet was constructed in Escherichia coli strain, and a total Ala-Gln yield/the molar yield were 69.7 g/L and 67% within 40 min, respectively [8]. In our previous research, OPA, the optimum engineered E. coli strain expressing SsAet from S. siyangensis SY1 (named OPA), achieved the highest Ala-Gln production with the maximum molar yield of 94.7% and productivity of 1.89 g/L/min. Furthermore, OPA could maintain fast reaction rate (~ 10 min), high Ala-Gln yields and enzyme stabilities after several cell recycling [20].

It is worth noting that the biosafety of products is vital and cannot be ignored in the food, healthcare, and medicine. Although satisfactory results had been obtained with recombinant E. coli OPA, endotoxin and the use of multiple antibiotics along with toxic inducer (IPTG) brought the potential biosafety hazard for the clinical application of Ala-Gln. Here, we used the safer host P. pastoris to produce Ala-Gln which was added to the qualified presumption of safety (QPS) list by the European Food Safety Authority (EFSA) in 2008 [21]. The safety is further increased by integrated expression of the heterologous gene without antibiotics addition, and the inducer methanol was easily removed by evaporation in the purified process of Ala-Gln. To improve the expression efficiency of SsAet derived from bacteria in P. pastoris, codon optimization was first performed. Subsequently, the optimization of the cultivation and reaction conditions were investigated to achieve higher catalytic activity. On this basis, immobilization by agar embedding and recycle were carried out to further improve the catalytic stability and production efficiency. Therefore, a new yeast system using P. pastoris GS115 overexpressing SsAet was employed to better the prokaryotic system, which may lay a good foundation for the further industrial-scale clean production of Ala-Gln.

Materials and methods

Strains and media

Strains and plasmids used in this study were described in Table 1. For routine use, cultures were maintained on Luria–Bertani (LB) medium (0.5% yeast extract, 1% tryptone, and 1% sodium chloride) agar slants supplemented with the corresponding antibiotics as needed or yeast extract peptone dextrose (YPD) medium (1% yeast extract, 2% peptone, and 2% dextrose) agar slants at 4 °C. For long-term storage, cultures were frozen at − 80 °C in 20% glycerol. The preparation of several different media was required to select and culture the transformants of strain P. pastoris GS115 as follows. Regeneration Dextrose Base (RDB) medium (1 M sorbitol, 2% dextrose, 1.34% YNB, 4*10−5 % biotin, l-lysine, l-glutamic acid, l-leucine, l-methionine, l-isoleucine each at 0.005%, and 2% agar) for screening His+ transformants, minimal dextrose (MD)/minimal methanol (MM) medium (1.34%YNB, 4*10−5 % biotin, 2% agar, and 2% dextrose or 0.5% methanol) for selecting the phenotype of transformants with Mut+ or Muts methanol utilization, and buffered glycerol-complex (BMGY)/buffered methanol-complex (BMMY) medium (1.34%YNB, 1% yeast extract, 2% peptone, 4*10−5 % biotin, 0.1 M potassium phosphate with pH 6.0, and 1% glycerol or 0.5% methanol) for growth/induction of recombinant strains were prepared on the basis of a manual of Pichia Expression Kit [22, 23, 24].
Table 1

Descriptions of strains and plasmids used in this study

Strain or plasmid

Description

Source

Original strains

 S. siyangensis SY1

Template of alpha-amino acid ester acyl transferase gene (SsAET)

CGMCC (1.6855)

 E. coli DH5α

Genetic manipulation

Solarbio (C1100)

 E. coli TOP10

Genetic manipulation

Solarbio (C1210)

 P. pastoris GS115

Methylotrophic yeast, capable of metabolizing methanol as individual sole carbon source; a mutation in the histidinol dehydrogenase gene (HIS4); histidine auxotroph

Invitrogen (C18100)

Recombinant strains

 TOP10-pUC57-SsAETp

pUC57-SsAETp plasmid in TOP10; ampicillin-resistant

This study

 DH5α-pPIC9-SsAETp

pPIC9-SsAETp plasmid in DH5α; ampicillin-resistant

This study

 DH5α-pPIC9-SsAET

pPIC9-SsAET plasmid in DH5α; ampicillin-resistant

This study

 GS115-pPIC9-SsAETp (GPAp)

pPIC9-SsAETp plasmid in P. pastoris GS115; His+ MutS

This study

 GS115-pPIC9-SsAET (GPA)

pPIC9-SsAET plasmid in P. pastoris GS115; His+ MutS

This study

Plasmids

 pPIC9

Empty vector; P. pastoris HIS4 vector for methanol-inducible expression of a secreted protein; ampicillin-resistant

Invitrogen (K1710-01)

 pUC57-SsAETp

pUC57 vector harboring SsAETp gene which codon-optimized SsAET gene according to codon bias of P. pastoris; ampicillin-resistant

This study

 pPIC9-SsAETp

pPIC9 vector harboring SsAETp gene; ampicillin-resistant

This study

 pPIC9-SsAET

pPIC9 vector harboring SsAET gene; ampicillin-resistant

This study

Construction of expression vectors

SsAET gene from S. siyangensis SY1 was PCR-amplified using the forward primer SsAET-F (EcoRI restriction site underlined), and the reverse primer SsAET-R (NotI restriction site underlined) as shown in Table 2. While both SsAET gene and pPIC9 vector were digested with restriction enzymes (EcoRI and NotI), the expression vector pPIC9-SsAET was assembled and stored in E. coli DH5α in the presence of ampicillin resistance. Simultaneously, the pUC57-SsAETp vector was obtained from Sangon (Shanghai, China), which harbored the codon-optimized gene SsAETp with the P. pastoris codon usage. Then, SsAETp gene was extracted using the same restriction enzymes (EcoRI and NotI) from the vector pUC57-SsAETp. As mentioned above, the expression vector pPIC9-SsAETp was generated and stored in E. coli DH5α in the presence of ampicillin resistance after being confirmed by enzyme digestion and DNA sequencing.
Table 2

Primers used in this work and EcoRI and NotI sites were lowercase italic

Primers

Sequence (5′–3′)

Purpose

SsAET-F

CGACGGgaattcATGAAAAATACAATTTCGTGCC

SsAET clone

SsAET-R

ATAAGAATgcggccgcCTAATGGTGATGGTGATGATGATCTTTGAGGACAGAAAATTCG

SsAET clone

GS115-F

CAGCTTTGATGCCTGAAATC

PCR verification for both

GPA-R

GCATCCTGAAGAAACAATACG

PCR verification for GPA

GPAp-R

CATTCCAGAATTGAACGGAG

PCR verification for GPAp

AOX1-F

CTGGTTCCAATTGACAAGC

DNA sequencing for both

AOX1-R

TGGCATTCTGACATCCTC

DNA sequencing for both

Transformation and selection for integrated transformants

pPIC9-SsAET plasmids, isolated from DH5α-pPIC9-SsAET, were linearized with restriction enzyme BglII and transformed into electro competent cells of P. pastoris GS115 following the protocol of Invitrogen. Subsequently, there were three steps to screen for the correct His+ MutS transformants: (1) His+ phenotype selection. RDB medium selectively allows the growth of recombinant strains with the integrated BglII-linearized fragment of pPIC9-SsAET, and was utilized to achieve the His+ phenotype; (2) MutS phenotype screening based on His+ phenotype. MutS phenotype rarely metabolizes methanol as a sole carbon source due to the disruption of AOX1 gene, which was readily selected according to the distinct growth behavior on MD/MM agar plates; (3) His+ MutS transformants were confirmed by PCR analysis using the forward primer GS115-F derived from the AOX1 promoter upstream 120 bp of P. pastoris GS115 chromosome 4 (GenBank: FN392322.1) and the reverse primer GPA-R/GPAp-R derived from about 650 bp in the middle of the target gene. After DNA sequencing using AOX1-F and AOX1-R, the His+ MutS transformant was named as GS115-pPIC9-SsAET (GPA). Similarly, the GS115-pPIC9-SsAETp (GPAp) which includes a codon-optimized SsAETp was also constructed as above for further assays. All primers involved are listed from 5′ to 3′ direction in Table 2.

Expression of target proteins and optimization of induction conditions

Pichia pastoris transformants (GPA or GPAp) were cultured using 25 mL BMGY medium in 250-mL flask at 30 °C, 220 rpm for 16–18 h. Then, cells were harvested by centrifuging and resuspended to an initial OD600 of 1.0 in 100 mL BMMY fresh medium/500-mL flask with vigorous shaking (250 rpm) at 30 °C. As an inducer, absolute methanol was supplemented to a final concentration of 1.0% (v/v) every 24 h for 120 h (5 days).

To further improve expression levels, the different induction conditions were optimized, including induction temperatures (18 °C, 20 °C, 22 °C, 24 °C, 26 °C, 28 °C, and 30 °C), final concentrations of inducer (0.5%, 1.0%, 1.5%, 2.0%, and 2.5%), and induction time (2 days, 3 days, 4 days, 5 days, and 6 days).

Ala-Gln production assay

Gln, AlaOMe and Ala-Gln were purchased from Sangon and Aladdin Industrial Corporation (China). Ala-Gln production using GPA or GPAp as the whole-cell biocatalyst was performed as follows: the substrates (100 mM AlaOMe and 100 mM Gln) were directly added to 100 mL cultures after induction, while controlling pH at 8.5 by 6 M NaOH. The enzyme-catalyzed reaction was maintained at 24 °C for 10 min, and then terminated by centrifugation (10,000g, 2 min) and heat inactivation (100 °C, 5 min) successively. All samples were temporarily stored at 4 °C for the high performance liquid chromatography (HPLC) analysis.

Optimization of enzyme-catalyzed reactions

The optimal catalytic reaction conditions were investigated. Reaction temperatures were 20 °C, 22 °C, 24 °C, 26 °C, 28 °C, and 30 °C at pH 8.5; reaction pH was performed among 7.0, 7.5, 8.0, 8.5, 9.0, and 9.5. Besides, various types of amino acid esters were selected as substrates to increase the production of Ala-Gln, such as l-alanine methyl ester hydrochloride (AlaOMe), l-alanine ethyl ester hydrochloride (AlaOEt), l-alanine isopropyl ester hydrochloride (AlaOiPr), l-alanine tert-butyl ester hydrochloride (AlaOtBu), and l-alanine benzyl ester hydrochloride (AlaOBzl). Also, the ratios of AlaOMe/Gln were conducted at 1/1, 1/1.5, 1/2, 1.5/1, and 2/1 to achieve the maximum molar yield in different experimental groups. Subsequently, the different substrate concentrations (AlaOMe-Gln = 150–100, 300–200, 450–300, 600–400, 900–600 mM) with the same ratio of AlaOMe/Gln = 1.5/1 were demonstrated in this study. Besides, in order to further improve the enzyme activity, the reaction was carried out with different additives containing metal ions (K+, Na+, Ca2+, Mg2+, Zn2+, Fe2+, and Fe3+), activator (cysteine) and protease inhibitor (EDTA and PMSF) to a final concentration of 10 mM.

HPLC analysis of Ala-Gln

Activities of SsAet from GPA or GPAp and Ala-Gln formation were detected by HPLC utilizing C18 column (ODS-3, 4.6*250 mm, 5 μm; GL Sciences Inc., Japan). A detailed method was described previously [20].

Catalytic stability, immobilization, and reusability of GPAp

The catalytic stability of SsAet from GPAp was examined from two aspects. One was stored in the mild pH of 7.2 at 4 °C for 5 days. The other was stored under the optimal reaction pH and temperature (8.5 and 28 °C) for the same time (5 days). Activities of different time points were detected as mentioned above methods.

To promote the possibility of further industrialization, the immobilization of GPAp cells were carried out. The cell pellet was harvested by centrifugation and resuspended in 10 mL phosphate buffer. The prepared cell pellet was instantly mixed with 10 mL 4% (w/v) agar solution which was kept warm in a 55 °C water bath [25, 26]. Then the mixture was slowly dropped in an ice water–oil immiscible solvent to form uniform spherical beads (diameter approximately 3–4 mm). The agar beads were washed and stored with phosphate buffer at 4 °C for the test of the recycle. In this study, 10 cycles of catalytic reactions were performed under the same reaction conditions described above to evaluate the reusability of immobilized cells.

Results and discussion

Codon optimization of SsAET gene based on P. pastoris

Based on our previous research [20], the complete nucleotide sequence of our SsAET gene from S. siyangensis SY1 was 98% identical with SsAET from S. siyangensis AJ2458 (GenBank: AB610978.1). Correspondingly, an enzyme SsAet contains 619 amino acids, and the molecular weight was estimated at approximately 71.03 kDa. Compared with the SsAet from AJ2458, three mutated amino acids were found in the unique enzyme SsAet from SY1, which might cause an unanticipated change of enzyme structure and an improved enzyme-catalyzed activity [27, 28].

The target proteins in heterologous hosts are often difficult to function normally because of the codon bias [29]. There are 61 nucleotide triplets (codons) to encode 20 amino acids, but the choice of synonymous codons in different species is strongly biased [30]. A considerable divergence (60%) between prokaryotic and P. pastoris codon bias is extremely obvious as shown in Additional file 1: Figure S1. In order to solve the potential problem and improve the expression efficiency, codon optimization was supposed to be a reasonable choice. As an attempt to this end, a 1878 bp DNA sequence (18 bp 6*His tag appended to 1860 bp gene) was optimized for better protein expression in P. pastoris. Several rules including but not limited to the following were adjusted: (1) codon usage bias was adjusted to fit the highest expression profile of the target host, and a CAI (codon adaptation index) of 0.8–1.0 is regarded as good for high expression; (2) the ideal percentage range of GC content is between 30 and 70%, perfectly 40–60% and unfavorable GC peaks were removed; (3) undesired motif including restriction enzyme site to be used in sub-cloning and negative cis-acting sites were modified; (4) whole sequence was fine-tuned to increase the translation efficiency and prolong the half-life of mRNA.

Therefore, Fig. 1 showed that some infrequent codons in the original gene SsAET were selectively replaced by high-frequency codons of P. pastoris in the synthesized gene SsAETp based on the above principles. As a result, a total of 384 non-preferred codons in the original gene SsAET were substituted by the preferred codons of P. pastoris in the synthesized gene SsAETp, which represents 61.3% of the overall amino acid sequence (Additional file 1: Figure S2). Moreover, CAI was upgrading from 0.69 to 0.89 and the average GC content was adjusted to 40.3%. Thus, the codon-optimized gene was inserted into the pPIC9 vector and transferred into P. pastoris to construct the recombinant strain GPAp, while the original gene was used as the control to construct the recombinant strain GPA.
Fig. 1

Codon usage bias adjustment of SsAET gene. Colors of codons indicated the frequency in host P. pastoris. Rarely used codons were shown in cyan and frequently used codons were shown in red. A codon with more red indicated higher frequency in P. pastoris for enhanced expression

Screening of the optimized Ala-Gln producer

Several candidates of His+ MutS transformants were found on MD/MM agar plates, which were confirmed by PCR analysis. Lane 2, 18, and 20 all showed the approximately 2000 bp PCR product containing 1200 bp partial vector fragment (120 bp + 650 bp + 1200 bp = 1970 bp), which indicated the AOX1 gene was accurately replaced by linearized interest gene fragment. After DNA sequencing, His+ MutS transformants were successfully obtained including GPA and GPAp (Additional file 1: Figure S3).

After the induction, the supernatant and cells were first used to measure the enzyme activity, respectively. Unexpectedly, the enzyme activity of cells was approximately 10 times than that of the supernatant (Additional file 1: Figure S4). A possible reason is that the size and structure of the protein multimer which forms in the cells block protein secretion. Therefore, GPA and GPAp as a whole-cell biocatalyst were used to synthesize Ala-Gln in subsequent studies. For the sake of screening the optimized Ala-Gln producer, GPA and GPAp were investigated under the same cultural and reaction conditions following “Materials and methods”, and Ala-Gln formation was measured by HPLC. As shown in Fig. 2, the production of Ala-Gln by GPAp was an approximately 2.5-fold increase in comparison with GPA’s when the Ala-Gln accumulation of GPAp reached maximum, indicating the positive effect of codon optimization in heterologous expression. Codon optimization was practically beneficial to improve the expression levels of heterogenous gene, thereby increasing the enzyme-catalyzed activity. As a result, GPAp (whole-cell biocatalyst) was defined as the more suitable Ala-Gln producer for the further study.
Fig. 2

Comparison of catalytic activity between GPA and GPAp to screen for the optimum Ala-Gln producer. GPA and GPAp were denoted in grey and orange, respectively. Samples at two time points were detected by HPLC

Optimization of induction conditions for Ala-Gln production by GPAp

GPAp, as a direct whole-cell biocatalyst, was used to efficiently synthesize Ala-Gln. In order to further improve SsAet expression levels, a series of parameters in the induced process were worth being explored. Firstly, the effect of induction temperatures was investigated in the range of 18 to 30 °C. The results showed a stable positive correlation between Ala-Gln accumulation (or enzyme activity) and temperature from 18 to 26 °C, and yet an obvious decrease was detected when the temperature was over 26 °C (Fig. 3a), which implied the consistency between the optimal induction temperature and the appropriate cell growth temperature. Secondly, the different induction time was performed within 6 days. Results showed that the highest activity was detected after induction for 4 days, and the enzyme activities were 82.0% and 98.4% of the highest activity for 2 days and 3 days, respectively (Fig. 3b). Additionally, the concentrations of methanol rarely contributed to an enhanced Ala-Gln formation, which means that a moderate supplement was enough to maintain the high activity, as shown in Fig. 3b. Considering both the economy and efficiency, the optimal induction conditions, including temperature (26 °C), duration (for 3 days), and supplemented methanol concentration (1.5%) were determined for GPAp in the future assays. Compared with the prokaryotic induction conditions in the previous study [20], GPAp has two competitive advantages for the Ala-Gln production. On the one hand, it can be induced at room temperature with low equipment requirements; On the other hand, its inducer is easily removed by evaporation to ensure product biosafety.
Fig. 3

Effects of induction conditions on the catalytic activities of GPAp. a Induction temperatures of 18 °C, 20 °C, 22 °C, 24 °C, 26 °C, 28 °C, and 30 °C. b Induction time from 2 to 6 days. Blue line showed the different supplemented methanol concentrations of 0.5%, 1.0%, 1.5%, 2.0%, and 2.5%

Optimization of reaction conditions for Ala-Gln production by GPAp

Effects of reaction pH, temperature and substrate

Several reaction conditions were optimized using GPAp under the optimum induction conditions, while catalyzing AlaOMe and Gln to synthesize Ala-Gln. It could be determined that the optimal reaction temperature and pH for Ala-Gln production by GPAp were 28 °C and 8.5, respectively, according to the results of relative activities by HPLC. Additionally, GPAp could steadily maintain over 90% of the highest activity among a wide range of 24 to 30 °C. Similarly, the enzyme activities still remained over 85% of the highest activity when the pH was in the range of 8.5–9.5, whereas the enzyme almost completely inactivated when pH was near or less than 7 (Fig. 4a, b).
Fig. 4

Effects of reaction conditions on the Ala-Gln production. a Reaction temperature of 20 °C, 22 °C, 24 °C, 26 °C, 28 °C, and 30 °C at pH 8.5. b Reaction pH of 7.0, 7.5, 8.0, 8.5, 9.0, and 9.5 at 24 °C, adjusting with 6 mol/L NaOH. c Different amino acid esters, including AlaOMe, AlaOEt, AlaOiPr, AlaOtBu, and AlaOBzl. d Different ratios of AlaOMe/Gln of 1/1, 1/1.5, 1/2, 1.5/1, and 2/1

Moreover, the effect of different amino acid esters on Ala-Gln generation was detected. Results revealed that the Ala-Gln production using AlaOMe was much higher than others. Unfortunately, the production of Ala-Gln by AlaOBzl was barely detected in our experiments (Fig. 4c). These implied that SsAet from GPAp could selectively bind with preferred amino group bonding sites like methyl ester [31]. As shown in Fig. 4d, we further optimized the ratios of the two substrates (AlaOMe/Gln) to improve the enzyme activity and molar yields. The ratio of AlaOMe/Gln = 2/1 had the highest enzyme activity, which was approximately 1.4-fold higher than that of AlaOMe/Gln = 1/1. The enzyme activity of AlaOMe/Gln = 1.5/1 was in accordance with that of AlaOMe/Gln = 1/2, which still remained over 93% of the highest enzyme activity. The molar yields of Ala-Gln were 47.2%, 57.2%, 59.9%, 58.7%, and 62.8% among different ratios of AlaOMe/Gln = 1/1, 1/1.5, 1/2, 1.5/1, and 2/1. These results demonstrated that the molar yield was significantly improved when either substrate was excess. Hence, taking both the enzyme activity and cost into consideration, the ratio of AlaOMe/Gln = 1.5/1 was determined as the most suitable substrates for the further application.

Effects of metal ion, activator and protease inhibitor

Besides, the enzyme SsAet from GPAp was exposed to numerous additives (10 mM) containing various metal ions (K+, Na+, Ca2+, Mg2+, Zn2+, Fe2+, and Fe3+), activator (cysteine) and protease inhibitor (EDTA and PMSF) to examine the effect of additives on the catalytic activity. As shown in Table 3, the relative activities of GPAp were not obviously affected by K+, Na+, Ca2+, Mg2+, and Zn2+, which remained over 99% of the activity compared with blank control. However, the relative activity of GPAp showed a decreasing tendency in the presence of Fe3+. In contrast, a positive effect of Fe2+, cysteine, EDTA, and PMSF was detected, among which cysteine and PMSF achieved the most increase (approximately 17% and 13%), respectively. These implied that cysteine as a reducing agent might protect the sulfhydryl group of the enzyme from oxidation to improve the GPAp catalytic activity, while PMSF and EDTA could hamper protease and peptidase to avoid the degradation [32].
Table 3

Effects of various additives on the activity of GPAp

Additive (10 mM)

Relative enzymatic activity (%)

None

100.00 ± 0.00

K+

99.82 ± 0.63

Na+

101.52 ± 1.34

Ca2+

99.20 ± 1.06

Mg2+

101.44 ± 0.72

Zn2+

104.63 ± 3.04

Fe2+

108.36 ± 1.83

Fe3+

91.23 ± 4.39

Cysteine

116.50 ± 1.48

EDTA

107.13 ± 2.81

PMSF

112.59 ± 0.71

Accumulation and molar yield under different substrate concentrations

Based on the above optimal reaction conditions, Ala-Gln was synthesized by GPAp using the different substrate concentrations (AlaOMe-Gln = 150–100, 300–200, 450–300, and 600–400 mM) with a ratio of AlaOMe/Gln = 1.5/1. The curve of Ala-Gln production with time is shown in Fig. 5. GPAp could rapidly generate Ala-Gln within 20 min at a lower substrate concentration. As the substrate concentration increased, the reaction time was correspondingly extended to 40 min. And the yields and molar yields under various substrates were 63.5 mM/63.5%, 124.7 mM/62.3%, 181.4 mM/60.5%, and 227.9 mM/57.0%, respectively, which had a slight decrease (about 12–15%) in comparison with previous studies of OPA [20]. Unlike prokaryotic expression system, there is post-translational protein modification in yeast (eukaryotic expression system). Preliminary analysis suggested that the most direct cause of the difference in catalytic activities between OPA and GPAp was glycosylation, including N-linked glycosylation and O-linked glycosylation. Despite not yet being confirmed, four putative N-linked glycosylation sites and five putative O-linked glycosylation sites were predicted referring to the glycoprotein structure of higher eukaryotes [33]. However, only 7 sites with scores over 0.5 were supposed to be the positive glycosylation sites (Additional file 1: Figure S5). In the future experiments, we will adopt measures to avoid protein modification, such as deglycosylation with enzymes or removing the glycosylation sites. And the structures, functions, and modifications of the enzyme (SsAet) from different expressing systems will be specifically studied to illuminate catalytic mechanisms.
Fig. 5

The curves of Ala-Gln concentrations with time in different substrate concentrations

Ala-Gln was generally supposed to be an unstable product because of protease or peptidase hydrolysis [34]. Therefore, multiple related coding genes were knocked out in order to reduce the decomposition of Ala-Gln, but cell growth was usually hampered [35]. Fortunately, our results showed that the Ala-Gln generation by GPAp maintained even more stable than that of OPA within 60 min, which could be attributed to the inherent characteristics and growing environments of yeasts (lower pH than neutral pH) with less protease expression or inactivation of many proteases and peptidase [36]. Besides, when further increasing the substrate concentration to 900–600 mM, the GPAp could maintain a consistent production rate of Ala-Gln, which indicated that using the high substrate concentration did not inhibit the catalytic activity of GPAp and increased the feasibility of large-scale industrial production.

Reusability of immobilized GPAp

Stability and immobilization of GPAp

The catalytic stability of GPAp was investigated from two aspects as a prerequisite for subsequent experiments. On the one hand, a decrease of enzyme activity was barely detected when being stored in the mild pH of 7.2 at 4 °C for 5 days. On the other hand, GPAp could remain extremely stable (approximately 90%) under the optimal reaction conditions (pH of 8.5 at 28 °C) for 5 days as shown in Fig. 6a. These results demonstrated that GPAp had the excellent catalytic stability for long-term usage.
Fig. 6

Application of immobilized GPAp by recycling to maintain the stability of Ala-Gln production. a The catalytic activities of GPAp were detected daily by HPLC during the 5 days which GPAp was stored at the optimal reaction pH and temperature (8.5 at 28 °C). b The catalytic activities were detected and compared among free GPAp with one unit of OD600, immobilized GPAp with one unit of OD600 and immobilized GPAp with double OD600. c The reusability of immobilized GPAp was detected at optimum conditions for recycling 10 times

Additionally, GPAp was immobilized in agar beads to further improve the catalytic stability and increase the convenience of recycling. The related activities between free GPAp and immobilized GPAp were detected and compared. Results showed that the activity of the immobilized GPAp was half of that of free GPAp using the same biomass (OD600). When double biomass (OD600) was utilized, the residual activity remained over 70% (Fig. 6b). These results suggested that the higher immobilized temperature (55 °C) which caused the partial GPAp inactivation and mass transfer resistance led to the decreased enzyme activity. One could imagine that continuous increase of immobilized biomass (OD600) was practically an effective approach to achieve the similar enzyme activity of free GPAp.

Immobilized GPAp by recycling for efficient production

Based on both the catalytic stability and immobilization, the reusability of immobilized GPAp was subsequently investigated to realize a convenient, efficient and effective repeated-cycle batch production of Ala-Gln. Results showed that the catalytic activity of immobilized GPAp could remain terrific stability in the repeated-cycle batch experiments (10 cycles) as shown in Fig. 6c. Moreover, the immobilization was prepared using the method of water in oil (W/O), which retained an oil on the surface of the agar beads. When the oil was gradually removed due to the multiple recycling of beads, a slight increase was found in the first 5 cycles.

Pichia pastoris has its unique advantages on Ala-Gln production. As chassis cells, good biosecurity provides a greater possibility for the clinical application. As a catalyst carrier, the enzyme catalytic activity will be better maintained due to mild culture condition and less glycosylation. Consequently, it is anticipated that the industrial production Ala-Gln is likely to be realized with the immobilized GPAp by recycling from the following three aspects: (1) GPAp, as the mainstay of an overall process, is a greener approach without the drawbacks of the chemical method and potential biosafety hazards that caused by endotoxin and toxic inducer. Methanol added in our system is easily removed by evaporation, and an integrated genotype also avoids antibiotics addition; (2) the immobilized GPAp with an enhanced catalytic stability omits the recovery step by centrifuging after each reaction and had the advantages in time-saving, power-saving, and labor-saving; (3) the recyclable immobilized GPAp also avoids a repeated cell cultivation to reduce production costs, which conformed to the sustainable development strategy.

Conclusion

In this study, SsAet origin from a prokaryotic organism, had been characterised in P. pastoris GS115. GPAp with a codon-optimized SsAet was constructed and selected as the whole-cell biocatalyst for the production of Ala-Gln due to its excellent catalytic capacity and reliable biosafety. With the optimization of induction and reaction conditions, the immobilized GPAp for recycling represents a promising approach to achieve economic, efficient and practical Ala-Gln production. Furthermore, we provided a direction and foundation for further studies on enzymatic property of SsAet and indicated a green application for the unique enzyme in the industrial production of Ala-Gln.

Notes

Authors’ contributions

YML designed the research, performed most of the experiments, collected data and prepared the manuscript; JQG reviewed the obtained results and revised the manuscript; XZP, CD and CF conducted analyses, provided the suggestions and revised parts of the paper; WJY and FWB conceived the concept, participated in the design of the experiment and revised the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors would like to thank the financial supports from projects of International Cooperation and Exchanges NSFC (51561145014) and Dalian Innobio Corporation Limited (HX20160536).

Competing interests

All authors agree to the submission, and we confirm that no any competing interests, both financial and personal, are with this manuscript.

Availability of data and materials

All data generated or analysed during this study are included in this published article and its additional file, and the raw data are all available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This study was supported by projects of International Cooperation and Exchanges NSFC (51561145014) and Dalian Innobio Corporation Limited (HX20160536).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

References

  1. 1.
    Bergström J, Fürst P, Noree LO, Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol. 1974;36:693–7.  https://doi.org/10.1152/jappl.1974.36.6.693.CrossRefPubMedGoogle Scholar
  2. 2.
    Wernerman J. Suggestion for present and future use of parenteral glutamine. Clin Nutr Suppl. 2004;1:37–42.  https://doi.org/10.1016/j.clnu.2004.07.008.CrossRefGoogle Scholar
  3. 3.
    Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178:93–105.  https://doi.org/10.1083/jcb.200703099.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Castell LM. Glutamine supplementation in vitro and in vivo, in exercise and in immunodepression. Sports Med. 2003;33:323–45.  https://doi.org/10.2165/00007256-200333050-00001.CrossRefPubMedGoogle Scholar
  5. 5.
    Corbet C, Feron O. Metabolic and mind shifts: from glucose to glutamine and acetate addictions in cancer. Curr Opin Clin Nutr Metab Care. 2015;18:346–53.  https://doi.org/10.1097/MCO.0000000000000178.CrossRefPubMedGoogle Scholar
  6. 6.
    Gouw AM, Toal GG, Felsher DW. Metabolic vulnerabilities of MYC-induced cancer. Oncotarget. 2016;7:29879–80.  https://doi.org/10.18632/oncotarget.7223.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48:297–309.  https://doi.org/10.1111/j.1753-4887.1990.tb02967.x.CrossRefPubMedGoogle Scholar
  8. 8.
    Hirao Y, Mihara Y, Kira I, Abe I, Yokozeki K. Enzymatic production of l-alanyl-l-glutamine by recombinant E. coli expressing α-amino acid ester acyltransferase from Sphingobacterium siyangensis. Biosci Biotechnol Biochem. 2013;77:618–23.  https://doi.org/10.1271/bbb.120859.CrossRefPubMedGoogle Scholar
  9. 9.
    Fürst P. New developments in glutamine delivery. J Nutr. 2001;131:2562S–8S.  https://doi.org/10.1093/jn/131.9.2562S.CrossRefPubMedGoogle Scholar
  10. 10.
    Fürst P, Pogan K, Stehle P. Glutamine dipeptides in clinical nutrition. Nutrition. 1997;13:731–7.  https://doi.org/10.1016/S0899-9007(97)83035-3.CrossRefPubMedGoogle Scholar
  11. 11.
    Stehle P, Pfaendler P, Fürst P. Isotachophoretic analysis of a synthetic dipeptide l-alanyl-l-glutamine: evidence for stability during heat sterilization. J Chromatogr A. 1984;294:507–12.  https://doi.org/10.1016/S0021-9673(01)96174-6.CrossRefGoogle Scholar
  12. 12.
    Lochs H, Hübl W. Metabolic basis for selecting glutamine-containing substrates for parenteral nutrition. J Parenter Enteral Nutr. 1990;14:114S–7S.  https://doi.org/10.1177/014860719001400416.CrossRefGoogle Scholar
  13. 13.
    Brosnan JT. Interorgan amino acid transport and its regulation. J Nutr. 2003;133:2068S–72S.  https://doi.org/10.1093/jn/133.6.2068S.CrossRefPubMedGoogle Scholar
  14. 14.
    Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014;18:R76.  https://doi.org/10.1186/cc13836.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Yamamoto T, Shimoyama T, Kuriyama M. Dietary and enteral interventions for Crohn’s disease. Curr Opin Biotechnol. 2017;44:69–73.  https://doi.org/10.1016/j.copbio.2016.11.011.CrossRefPubMedGoogle Scholar
  16. 16.
    Akabori S, Sakakibara S, Shimonishi Y. Protection of amide-nitrogen for peptide synthesis A novel synthesis of peptides containing C-terminal glutamine. Bull Chem Soc Jpn. 1961;34:739.  https://doi.org/10.1246/bcsj.34.739.CrossRefGoogle Scholar
  17. 17.
    Hou J, Wang T, Lin K, Tang G, Zhao Y. Synthesis and mechanism studies on amide bond formation by hexamethylphosphoramide (HMPA). Phosphorus Sulfur Silicon Relat Elem. 2008;183:747–8.  https://doi.org/10.1080/10426500701807798.CrossRefGoogle Scholar
  18. 18.
    Yagasaki M, Hashimoto S. Synthesis and application of dipeptides; current status and perspectives. Appl Microbiol Biotechnol. 2008;81:13–22.  https://doi.org/10.1007/s00253-008-1590-3.CrossRefPubMedGoogle Scholar
  19. 19.
    Abe I, Hara S, Yokozeki K. Gene cloning and characterization of α-amino acid ester acyl transferase in Empedobacter brevis ATCC14234 and Sphingobacterium siyangensis AJ2458. Biosci Biotechnol Biochem. 2011;75:2087–92.  https://doi.org/10.1271/bbb.110181.CrossRefPubMedGoogle Scholar
  20. 20.
    Li Y, Yuan W, Gao J, Fan C, Wu W, Bai F. Production of l-alanyl-l-glutamine by recycling E. coli expressing α-amino acid ester acyltransferase. Bioresour Technol. 2017;245:1603–9.  https://doi.org/10.1016/j.biortech.2017.06.008.CrossRefPubMedGoogle Scholar
  21. 21.
    Sundh I, Melin P. Safety and regulation of yeasts used for biocontrol or biopreservation in the food or feed chain. Antonie Van Leeuwenhoek. 2011;99:113–9.  https://doi.org/10.1007/s10482-010-9528-z.CrossRefPubMedGoogle Scholar
  22. 22.
    Invitrogen. A manual of methods for expression of recombinant proteins in Pichia pastoris invitrogen method for expression. In: Catalog no. K1740-01. 2012. https://www.thermofisher.com/search/results?query=GS115&persona=DocSupport&navId=4294959596&refinementAction=true&focusarea=%C3%A6%C2%90%C2%9C%C3%A7%C2%B4%C2%A2%C3%A5%C2%85%C2%A8%C3%A9%C2%83%C2%A8.
  23. 23.
    Holmes WJ, Darby RA, Wilks MD, Smith R, Bill R. Developing a scalable model of recombinant protein yield from Pichia pastoris: the influence of culture conditions, biomass and induction regime. Microb Cell Fact. 2009;8:35.  https://doi.org/10.1186/1475-2859-8-35.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Luiz DP, Almeida JF, Goulart LR, Nicolau-Junior N, Ueira-Vieira C. Heterologous expression of abaecin peptide from Apis mellifera in Pichia pastoris. Microb Cell Fact. 2017;16:76.  https://doi.org/10.1186/s12934-017-0689-6.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Takahashi H, Li B, Sasaki T, Miyazaki C, Kajino T, Inagaki S. Catalytic activity in organic solvents and stability of immobilized enzymes depend on the pore size and surface characteristics of mesoporous silica. Chem Mater. 2000;12:3301–5.  https://doi.org/10.1021/cm000487a.CrossRefGoogle Scholar
  26. 26.
    Trelles JA, Bentancor L, Schoijet A, Porro S, Lewkowicz ES, Sinisterra JV, et al. Immobilized Escherichia coli BL21 as a catalyst for the synthesis of adenine and hypoxanthine nucleosides. Chem Biodivers. 2004;1:280–8.  https://doi.org/10.1002/cbdv.200490024.CrossRefPubMedGoogle Scholar
  27. 27.
    Matteucci E, Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem. 2009;16:2943–51.  https://doi.org/10.2174/092986709788803114.CrossRefPubMedGoogle Scholar
  28. 28.
    Nakagawa Y, Hasegawa A, Hiratake J, Sakata K. Engineering of Pseudomonas aeruginosa lipase by directed evolution for enhanced amidase activity: mechanistic implication for amide hydrolysis by serine hydrolases. Protein Eng Des Sel. 2007;20:339–46.  https://doi.org/10.1093/protein/gzm025.CrossRefPubMedGoogle Scholar
  29. 29.
    Lithwick G, Margalit H. Hierarchy of sequence-dependent features associated with prokaryotic translation. Genome Res. 2003;13:2665–73.  https://doi.org/10.1101/gr.1485203.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Holm L. Codon usage and gene expression. Nucleic Acids Res. 1986;14:3075–87.  https://doi.org/10.1093/nar/14.7.3075.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Hara S, Yokozeki K, Abe I, Tonouchi N, Jojima Y. Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe. U.S. Patent. 2013. No. 8,389,241. https://patents.google.com/patent/US8389241B2/en.
  32. 32.
    Chen JM, Chen WT. Fibronectin-degrading proteases from the membranes of transformed cells. Cell. 1987;48:193–203.  https://doi.org/10.1016/0092-8674(87)90423-5.CrossRefPubMedGoogle Scholar
  33. 33.
    Cregg JM, Vedvick TS, Raschke WC. Recent advances in the expression of foreign genes in Pichia pastoris. Nat Biotechnol. 1993;11:905.  https://doi.org/10.1038/nbt0893-905.CrossRefGoogle Scholar
  34. 34.
    Arkowitz RA, Bassilana M. Protein translocation in Escherichia coli. Biochim Biophys Acta Rev Biomembr. 1994;1197:311–43.  https://doi.org/10.1016/0304-4157(94)90012-4.CrossRefGoogle Scholar
  35. 35.
    Tabata K, Hashimoto S. Fermentative production of l-alanyl-l-glutamine by a metabolically engineered Escherichia coli strain expressing l-amino acid α-ligase. Appl Environ Microbiol. 2007;73:6378–85.  https://doi.org/10.1128/AEM.01249-07.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Brierley RA, Davis GR, Holtz GC. Production of insulin-like growth factor-1 in methylotrophic yeast cells. U.S. Patent. 1994. No. 5,324,639. https://patents.google.com/patent/US5324639A/en.

Copyright information

© The Author(s) 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.School of Life Science and BiotechnologyDalian University of TechnologyDalianChina
  2. 2.Division of BiotechnologyDalian Institute of Chemical PhysicsDalianChina
  3. 3.Research and Development CenterDalian Innobio Corporation LimitedDalianChina
  4. 4.School of Life Science and BiotechnologyShanghai Jiaotong UniversityShanghaiChina

Personalised recommendations